Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
- PMID: 384241
- DOI: 10.1056/NEJM197909273011303
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
Abstract
One hundred and fifty patients with advanced cancer participated in a controlled double-blind study to evaluate the effects of high-dose vitamin C on symptoms and survival. Patients were divided randomly into a group that received vitamin C (10 g per day) and one that received a comparably flavored lactose placebo. Sixty evaluable patients received vitamin C and 63 received a placebo. Both groups were similar in age, sex, site of primary tumor, performance score, tumor grade and previous chemotherapy. The two groups showed no appreciable difference in changes in symptoms, performance status, appetite or weight. The median survival for all patients was about seven weeks, and the survival curves essentially overlapped. In this selected group of patients, we were unable to show a therapeutic benefit of high-dose vitamin C treatment.
Similar articles
-
Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?P R Health Sci J. 2010 Sep;29(3):215-7. P R Health Sci J. 2010. PMID: 20799507 Review.
-
High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.Anticancer Res. 2009 Mar;29(3):809-15. Anticancer Res. 2009. PMID: 19414313 Review.
-
Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study.Eur J Obstet Gynecol Reprod Biol. 2004 Nov 10;117(1):70-5. doi: 10.1016/j.ejogrb.2004.02.032. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15474248 Clinical Trial.
-
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.N Engl J Med. 1985 Jan 17;312(3):137-41. doi: 10.1056/NEJM198501173120301. N Engl J Med. 1985. PMID: 3880867 Clinical Trial.
-
Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis.N Engl J Med. 1979 Apr 5;300(14):756-9. doi: 10.1056/NEJM197904053001403. N Engl J Med. 1979. PMID: 370586 Clinical Trial.
Cited by
-
Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area.medRxiv [Preprint]. 2024 May 15:2024.05.15.24307403. doi: 10.1101/2024.05.15.24307403. medRxiv. 2024. PMID: 38798388 Free PMC article. Preprint.
-
Review of the Potential Role of Ascorbate in the Prevention and Treatment of Gynecological Cancers.Antioxidants (Basel). 2024 May 19;13(5):617. doi: 10.3390/antiox13050617. Antioxidants (Basel). 2024. PMID: 38790722 Free PMC article. Review.
-
The Influence of High-Dose Parenteral Vitamin C on the Incidence and Severity of Postoperative Pulmonary Complications in Cardiac Surgery with Extracorporeal Circulation: A Randomized Controlled Trial.Nutrients. 2024 Mar 7;16(6):761. doi: 10.3390/nu16060761. Nutrients. 2024. PMID: 38542673 Free PMC article. Clinical Trial.
-
Role of vitamins A, C, D, E in cancer prevention and therapy: therapeutic potentials and mechanisms of action.Front Nutr. 2024 Jan 11;10:1281879. doi: 10.3389/fnut.2023.1281879. eCollection 2023. Front Nutr. 2024. PMID: 38274206 Free PMC article. Review.
-
Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage.Antioxidants (Basel). 2023 Sep 18;12(9):1775. doi: 10.3390/antiox12091775. Antioxidants (Basel). 2023. PMID: 37760080 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
